Skip to main content
Clinical Trials/NCT07315243
NCT07315243Not yet recruitingNot Applicable

Modified Amniotic Fluid Scoring Model Incorporating Fetal Bladder Assessment

Assiut University0 sites70 target enrollmentStarted: January 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
70
Primary Endpoint
Sensitivity Of The Modified Amniotic Fluid Scoring Model

Study Overview

Brief Summary

This study will prospectively enroll pregnant women with singleton pregnancies between 20 and 38 weeks of gestation who attend Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid. The aim is to develop and validate a modified amniotic fluid scoring model that combines standard ultrasound measures of amniotic fluid volume with fetal bladder size and appearance. The study will compare the ability of this new scoring model to detect abnormal amniotic fluid volume against conventional ultrasound methods and will explore how fetal bladder measurements relate to amniotic fluid indices.

Detailed Description

This prospective observational cohort study will be conducted in the Obstetrics and Gynecology Department at Assiut University Hospital and will enroll 70 pregnant women aged 18-45 years with singleton pregnancies between 20 and 38 weeks of gestation who are referred for routine or clinically indicated ultrasound assessment of amniotic fluid volume. The study aims to develop and validate a modified amniotic fluid scoring model that integrates standard sonographic measures of amniotic fluid volume, including the amniotic fluid index and single deepest pocket, with predefined fetal bladder parameters such as bladder presence, morphology, and longitudinal and transverse diameters measured at maximal filling.

Eligible participants will undergo a standardized ultrasound examination using a high-resolution machine with a curvilinear transducer; the uterus will be systematically scanned to obtain AFI and single deepest pocket measurements, followed by a dedicated five-minute assessment of the fetal bladder to document its size, appearance, and any observed micturition events. All sonographic assessments will be performed by experienced sonographers following uniform protocols, and approximately 10 percent of examinations will be re-scanned by a second sonographer to assess interobserver reliability, with images and measurements digitally archived for blinded review.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pregnant women aged 18-45 years.
  • Singleton pregnancy between 20 and 38 weeks of gestation.
  • Women attending Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid volume.
  • No known major fetal anomalies at the time of inclusion.
  • Able and willing to provide written informed consent.

Exclusion Criteria

  • Multiple pregnancy (e.g., twins, triplets).
  • Pregnancies with known chromosomal or major structural fetal anomalies diagnosed prior to enrollment.
  • Maternal systemic diseases known to affect amniotic fluid volume (e.g., pregestational or gestational diabetes, chronic hypertension, renal disease).
  • Contraindications to ultrasound examination.
  • Inability to provide informed consent or anticipated poor compliance with study procedures.

Outcomes

Primary Outcomes

Sensitivity Of The Modified Amniotic Fluid Scoring Model

Time Frame: At the index obstetric ultrasound examination during pregnancy (single visit per participant).

Proportion of pregnancies with abnormal amniotic fluid volume (oligohydramnios or polyhydramnios) correctly identified as abnormal by the modified amniotic fluid scoring model incorporating fetal bladder assessment, using conventional ultrasound assessment (AFI/SDP) as the reference standard.

Secondary Outcomes

  • Correlation Between Fetal Bladder Size And Amniotic Fluid Volume(At the same index obstetric ultrasound examination during pregnancy (single visit per participant).)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Salah Eldin Ali Hassan

Resident at Obstetrics and Gynecology Department, Assiut University

Assiut University

Similar Trials